This study aimed to investigate the relationship between the combination of obesity and central obesity status and hyperuricemia, with a particular focus on normal weight with central obesity. Among individuals aged 40–64 years who underwent a health checkup conducted by the All Japan Labor Welfare Foundation in fiscal year 2014 (baseline), those who underwent the same health checkup in fiscal year 2019 were investigated. A body mass index (BMI) of ≥18.5kg/m
2 but<25kg/m
2 indicated normal weight, whereas a BMI of ≥25 kg/m
2 defined obesity. Waist-to-height ratios of <0.5 and ≥0.5 indicated the absence and presence of central obesity, respectively. Subjects were grouped into four according to the combination of obesity and central obesity status: “normal weight without central obesity,” “normal weight with central obesity,” “obesity without central obesity,” and “obesity with central obesity.” A uric acid level of>7.0mg/dl in men and ≥6.0 mg/dl in women or currently receiving treatment for hyperuricemia indicated hyperuricemia. The odds ratio (OR) and 95% confidence interval (95% CI) for hyperuricemia were calculated using logistic regression analysis. In total, 49,354 individuals (34,142 men; 15,212 women) were analyzed. Compared with the “normal weight without central obesity” group, the “normal weight with central obesity” group was more likely to develop hyperuricemia, obtaining an OR of 1.31 (95% CI, 1.19-1.43) for men and 1.89 (1.63-2.20) for women. Similar results were obtained after adjusting for age, smoking status, alcohol consumption, physical activity, hypertension, dyslipidemia, and diabetes. Hyperuricemia incidence differed depending on central obesity status even among individuals with normal weight. Therefore, normal weight with central obesity may be considered in hyperuricemia prevention.
View full abstract